Olaparib in the metastatic HER2-negative breast cancer setting von Zhukova, L. G., Khatkova, E. I., Ganshina, I. P., Kolyadina, I. V., Lubennikova, E. V.

Volltext

Ixabepilone: new perspectives for its use in breast cancer von A. A. Mescheryakov, E. V. Lubennikova, M. E. Abramov

Volltext

Russian multicenter experience of using talazoparib in the treatment of patients with BRCA-associated metastatic breast cancer von Semiglazova, T. Yu, Lubennikova, E. V., Bolotina, L. V., Orlova, R. V., Moiseenko, F. V., Avramenko, A. V., Artemeva, E. V., Borozdina, S. A., Vakhitova, A. A., Volkov, N. M., Ganshina, I. P., Dzhalilova, Sh. A., Zhukova, L. G., Kasparov, B. S., Kachmazov, A. A., Klimenko, V. V., Kornietskaya, A. I., Meshcheryakov, A. A., Paichadze, A. A., Poltoratsky, A. N., Ryabishina, O. E., Stepanova, M. L., Imyanitov, E. N

Volltext

Ribociclib for the treatment of hormone-positive HER2-negative breast cancer von Ganshina, I. P., Filonenko, D. A., Gordeeva, O. O., Lubennikova, E. V., Kolyadina, I. V., Mescheryakov, A. A.

Volltext

Ribociclib in 1st line HR+ breast cancer treatment von Zhukova, L G, Ganshina, I P, Gordeeva, O O, Lubennikova, E V

Volltext

Therapy of BRCA-associated metastatic breast cancer. Efficacy and safety of talazoparib in the real-world clinical practice von Lubennikova, E. V., Kornietskaya, A. L., Dorofeeva, N. S., Rossokha, E. I., Markarova, E. V., Yudina, I. V., Bazaeva, I. Y., Bolotina, L. V., Deshkina, T. I., Zhulikov, Ya. A., Stasenko, E. V., Ustinova, T. V., Tsareva, A. S., Artamonova, E. V.

Volltext

Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case von I V Kolyadina, I P Ganshina, L G Zhukova, A G Abdullaev, Yu Yu Andreeva, T Yu Danzanova, G T Sinyukova, D V Komov, N A Kozlov, D A Filonenko, O O Gordeeva, E V Lubennikova

Volltext